A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies

Oncotarget

Volumn 6, Issue 25, 2015, Pages 20829-20839

  Drusco, Alessandra ^a   Bottoni, Arianna ^a   Lagana', Alessandro ^b   Acunzo, Mario ^a   Fassan, Matteo ^c   Cascione, Luciano ^e,f   Antenucci, Anna ^d   Kumchala, Prasanthi ^a   Vicentini, Caterina ^g   Gardiman, Marina P ^c   Alder, Hansjuerg ^a   Carosi, Mariantonia A ^d   Ammirati, Mario ^a   Gherardi, Stefano ^h   Luscri', Marilena ^h   Carapella, Carmine ^d   Zanesi, Nicola ^a   Croce, Carlo M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e INSTITUTE OF ONCOLOGY RESEARCH   (Switzerland)

^f ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^g UNIVERSITY AND HOSPITAL TRUST OF VERONA   (Italy)

^h SANDRO PERTINI HOSPITAL   (Italy)

Author keywords

Biomarkers; Brain tumors; Cerebro spinal f luid (CSF); microRNA

Indexed keywords

MICRORNA; MICRORNA 125B; MICRORNA 223; MICRORNA 451; MICRORNA 711; MICRORNA 935; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CENTRAL NERVOUS SYSTEM METASTASIS; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPHOMA; MEDULLOBLASTOMA; NANODROP ASSAY; NANOSTRING TECHNIQUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SPECTROPHOTOMETER; BIOPSY; BRAIN TUMOR; CANCER STAGING; CEREBROSPINAL FLUID; DIFFERENTIAL DIAGNOSIS; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NANOTECHNOLOGY; PROCEDURES;

BIOMARKERS; BIOMARKERS, TUMOR; BIOPSY; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CEREBROSPINAL FLUID; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION; MICRORNAS; NANOTECHNOLOGY; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84940730294     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4096     Document Type: Article

References (39)

1. Berghoff AS, Stefanits H, Woehrer A, Heinzl H, Preusser M, Hainfellner JA. Vienna Comprehensive Cancer Center Central Nervous System Unit. Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers. Clin Neuropathol. 2013; May-Jun 32:148-58.
2. Zou P, Xu H, Chen P, Yan Q, Zhao L, Zhao P, Gu A. IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis. PLoS One. 2013; Jul 22;8:e68782.
3. von Deimling A, Korshunov A, Hartmann C. The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations. Brain Pathol. 2011; Jan 21:74-87.
4. Ichimura K, Nishikawa R, Matsutani M. Molecular markers in pediatric neuro-oncology. Neuro Oncol. 2012 Sep; 14 Suppl 4:iv90-9.
5. Reclawowicz D, Stempniewicz M, Stempniewicz M, Biernat W, Limon J, Sloniewski P. Loss of genetic material 1p and 19q chromosomal arms in low grade gliomas of central nervous system. Folia Neuropathol. 2013; 51:26-32.
6. Ryan SL, Schwalbe EC, Cole M, Lu Y, Lusher ME, Megahed H, O'Toole K, Nicholson SL, Bognar L, Garami M, Hauser P, Korshunov A, Pfister SM, et al. MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma. Acta Neuropathol. 2012; Apr 123:501-13.
7. Pekmezci M, Perry A. Neuropathology of brain metastases. Surg Neurol Int. 2013 May 2;4:S245-55.
8. Al-Shamy G, Sawaya R. Management of brain metastases: the indispensabile role of surgery. J Neurooncol. 2009; 91:275-282.
9. Mills SJ, Thompson G, Jackson A. Advanced magnetic resonance imaging biomarkers of cerebral metastases. Cancer Imaging. 2012; 12:245-252.
10. Aker VF, Hakan T, Karadereler S, Erkan M. Accuracy and diagnostic yeild of stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimens. Neuropathology. 2005; 25:207-213.
11. Vaquero J, Martinez R, Manrique M. Stereotactic biopsy for brain tumors: is it always necessary?. Surg. Neurol. 2000; 53:432-437.
12. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116:281-297.
13. Calin GA, Croce CM. MicroRNAs signature in human cancer. Nat Rev Cancer. 2006; 6:857-866.
14. Cho WC. OncomiRNAs: the discovery and progress of microRNAs in cancer. Mol Cancer. 2007; 6:60.
15. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA. 2001; 98:15149-15154.
16. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, et al. MicroRNA expression profiles classify human cancer. Nature. 2005; 435:834-838.
17. Ma XJ, Patel R, Wang X, Salunga R, Murage J, Desai R, Tuggle JT, Wang W, Chu S, Stecker K, Raja R, Robin H, Moore M, et al. Molecular classification of human cancer using a 92-gene real-time quantitative polymerase chain reaction assay. Arch Pathol Lab Med. 2006; 139:465-473.
18. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, et al. A microRNA expression signature of human solid tumors define cancer gene targets. Proc Natl Acad Sci USA. 2006; 103:2257-2261.
19. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008; 26:462-469.
20. Baraniskin A, Kuhnhenn J, Schlegel U, Schmiegel W, Hahn S, Schroers R. MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous sytem lymphoma. J. Neurooncol. 2012; 109:239-244.
21. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, Galas DJ, Wang K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010; 56:1733-1741.
22. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA, Lawler S. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008; 68:9125-9130.
23. Gal H, Pandi G, Kanner AA, Ram Z, Lithwick-Yanai G, Amariglio N, Rechavi G, Givol D. Mir-451 and Imatinib mesylate inhibit tumor growth of glioblastomas stem cells. Biochem Biophys Res Commun. 2008; 376:86-90.
24. Godlewski J, Nowicki MO, Bronisz A, Nuovo G, Palatini J, De Lay M, Van Brocklyn J, Ostrowski MC, Chiocca EA, Lawler SE. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol Cell. 2010; Mar 12;37:620-632.
25. Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha RK, Richardson JC, Saunders AM, et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathway. J Alzheimers Dis. 2008; 14:27-41.
26. Ralfkiaer U, Hagedorn PH, Bangsgaard N, Løvendorf MB, Ahler CB, Svensson L, Kopp KL, Vennegaard MT, Lauenborg B, Zibert JR, Krejsgaard T, Bonefeld CM, Søkilde R, et al. Diagnostic microRNA profiling in cutaneous T-cell Lymphoma (CTCL). Blood. 2011; 118:5891-5900.
27. Freilich RW, Woodbury ME, Ikezu T. Integrated expression profiles of mRNA and miRNA in polarized primary murine micfroglia. PloS One. 2013; 8:e79416.
28. Le MT, Xie H, Zhou B, Chia PH, Rizk P, Um M, Udolph G, Yang H, Lim B, Lodish HF. MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol Cell Biol. 2009; 29:5290-5305.
29. Xia HF, He TZ, Liu CM, Cui Y, Song PP, Jin XH, Ma X. MiRNA-125b expression affects the proliferation and apoptosis of human glioma cells by targeting Bmf. Cell Physiol Biochem. 2009; 23:347-358.
30. Jin Z, Xu S, Yu H, Yang B, Zhao H, Zhao G. MirR-125b inhibits Connexin43 and promotes glioma growth. Cell Mol Neurobiol. 2013; 33:1143-1148.
31. Le MT, The C, Shyn-Chang N, Xie H, Zhou B, Korzh V, Lodish HF, Lim B. MicroRNA-125b is a novel negative regulator of p53. Gen Dev. 2009; 23:862-876.
32. Smits M, Wurdinger T, van het Hof B, Drexhage JA, Geerts D, Wesseling P, Noske DP, Vandertop WP, de Vries HE, Reijerkerk A. Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma. FASEB J. 2012; 26:2639-2647.
33. Shi L, Zhang J, Pan T, Zhou J, Gong W, Liu N, Fu Z, You Y. MirR-125b is critical for the suppression of human U251 glioma stem cells proliferation. Brain Res. 2010; 1312:120-126.
34. Ferretti E, De Smaele E, Miele E, Laneve P, Po A, Pelloni M, Paganelli A, Di Marcotullio L, Caffarelli E, Screpanti I, Bozzoni I, Gulino A. Concerted microRNA control of Hedgehog signaling in cerebellar neuronal progenitor and tumor cells. EMBO, J. 2008; Oct 8;27:2616-27.
35. Henriksen M, Johnsen KB, Olesen P, Pilgaard L, Duroux M. MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme. Neuromolecular Med. 2014; Sep 16:565-577.
36. Genovese G, Ergun A, Shukla SA, Campos B, Hanna J, Ghosh P, Quayle SN, Rai K, Colla S, Ying H, Wu CJ, Sarkar S, Xiao Y, et al. MicroRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-( signaling in glioblastoma. Cancer Discover. 2012; 2:736-749.
37. Glasgow SM, Laug D, Brawley VS, Zhang Z, Corder A, Yin Z, Wong ST, Li XN, Foster AE, Ahmed N, Deneen B. The miR-223/Nuclear Factor I-A axis regulates glial precursor proliferation and tumorigenesis in the CNS. J Neurosci. 2013; 33:13560-13568.
38. Huang BS, Luo KZ, Han Y, Li XB, Cao LJ, Wu LX. MicroRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6. Oncol Rep. 2013; Nov 30;5:2263-2269.
39. Nuovo GJ, Elton TS, Nana-Sinkam P, Volinia S, Croce CM, Schmittgen TD. A methodology for the combined in situ analyses of the precursors and mature forms of microRNAs and correlation with their putative targets. Nat Protoc. 2009; 4:107-115.